Literature DB >> 21518343

Infectious causes of seizures and epilepsy in the developing world.

Pratibha Singhi1.   

Abstract

Central nervous system (CNS) infections are the main cause of seizures and acquired epilepsy in the developing world. Geographical variations determine the common causes in a particular region. Acute seizures are common in severe meningitis, viral encephalitis, malaria, and neurocysticercosis, and in most cases are associated with increased mortality and morbidity, including subsequent epilepsy. Neuronal excitability secondary to proinflammatory signals induced by CNS infections are an important common mechanism for the generation of seizures, in addition to various other specific mechanisms. Newer insights into the neurobiology of these infections and the associated epilepsy could help in developing neuroprotective interventions. Management issues include prompt treatment of acute seizures and the underlying CNS infection, correction of associated predisposing factors, and decisions regarding the appropriate choice and duration of antiepileptic therapy. Strategies for the prevention of epilepsy in CNS infections such as early anti-infective and anti-inflammatory therapy need scientific exploration. Prevention of CNS infections is the only definitive way forward to reduce the burden of epilepsy in developing countries. © The Author. Developmental Medicine & Child Neurology
© 2011 Mac Keith Press.

Entities:  

Mesh:

Year:  2011        PMID: 21518343     DOI: 10.1111/j.1469-8749.2011.03928.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  35 in total

1.  Neurotropic viral infections leading to epilepsy: focus on Theiler's murine encephalomyelitis virus.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Future Virol       Date:  2011-11       Impact factor: 1.831

Review 2.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

Review 3.  Epilepsy: A Spectrum Disorder.

Authors:  Joseph I Sirven
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-01       Impact factor: 6.915

4.  Complement Components Are Expressed by Infiltrating Macrophages/Activated Microglia Early Following Viral Infection.

Authors:  Jane E Libbey; Matthew F Cusick; Daniel J Doty; Robert S Fujinami
Journal:  Viral Immunol       Date:  2017-04-12       Impact factor: 2.257

5.  Imaging and Serological-Evidence of Neurocysticercosis Among Patients with Seizures in Odisha, an Unexplored Eastern Coastal Province in India.

Authors:  Priyadarshi Soumyaranjan Sahu; Shubhransu Patro; Payod Kumar Jena; Santosh Kumar Swain; Bidyut Kumar Das
Journal:  J Clin Diagn Res       Date:  2015-05-01

6.  Regulation of neuronal excitability by release of proteins from glial cells.

Authors:  Birte A Igelhorst; Vanessa Niederkinkhaus; Claudia Karus; Maren D Lange; Irmgard D Dietzel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

Review 7.  Neurocysticercosis.

Authors:  Pratibha Singhi; Renu Suthar
Journal:  Indian J Pediatr       Date:  2014-10-10       Impact factor: 1.967

Review 8.  Seizures in steroid-responsive encephalopathy.

Authors:  Xin Xu; Aolei Lin; Xuefeng Wang
Journal:  Neurol Sci       Date:  2020-11-21       Impact factor: 3.307

9.  Presynaptic L-Type Ca2+ Channels Increase Glutamate Release Probability and Excitatory Strength in the Hippocampus during Chronic Neuroinflammation.

Authors:  Giorgia Giansante; Antonella Marte; Alessandra Romei; Cosimo Prestigio; Franco Onofri; Fabio Benfenati; Pietro Baldelli; Pierluigi Valente
Journal:  J Neurosci       Date:  2020-08-03       Impact factor: 6.167

10.  The mechanism of neurogenic pulmonary edema in epilepsy.

Authors:  Hong Zhao; Guijun Lin; Mumu Shi; Jingquan Gao; Yanming Wang; Hongzhi Wang; Hongli Sun; Yonggang Cao
Journal:  J Physiol Sci       Date:  2013-10-20       Impact factor: 2.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.